UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Expression of MAGE-A3, NY-ESO-1, LAGE-1 and PRAME in urothelial carcinoma

British journal of cancer, 2012-06, Vol.107 (1), p.116-122

2012

Volltextzugriff (PDF)

The miR-143/-145 cluster regulates plasminogen activator inhibitor-1 in bladder cancer

British journal of cancer, 2012-01, Vol.106 (2), p.366-374

2012

Volltextzugriff (PDF)

Training and validation of a novel 4-miRNA ratio model (MiCaP) for prediction of postoperative outcome in prostate cancer patients

Annals of oncology, 2018-09, Vol.29 (9), p.2003-2009

2018

Volltextzugriff (PDF)

miR-145 induces caspase-dependent and -independent cell death in urothelial cancer cell lines with targeting of an expression signature present in Ta bladder tumors

Oncogene, 2010-02, Vol.29 (7), p.1073-1084

2010

Volltextzugriff (PDF)

PT08.2: Nutritional Status and Nutritional Risk in Patients with Neuroendocrine Tumors

Clinical nutrition (Edinburgh, Scotland), 2016-09, Vol.35, p.S37-S38

2016

Volltextzugriff (PDF)

A high resolution genomic portrait of bladder cancer: correlation between genomic aberrations and the DNA damage response

Oncogene, 2013-08, Vol.32 (31), p.3577-3586

2013

Volltextzugriff (PDF)

Prognostic significance of aberrantly silenced ANPEP expression in prostate cancer

British journal of cancer, 2013-02, Vol.108 (2), p.420-428

2013

Volltextzugriff (PDF)

Next-generation sequencing identifies germline MRE11A variants as markers of radiotherapy outcomes in muscle-invasive bladder cancer

Annals of oncology, 2014-04, Vol.25 (4), p.877-883

2014

Volltextzugriff (PDF)

Analysis of molecular intra-patient variation and delineation of a prognostic 12-gene signature in non-muscle invasive bladder cancer; technology transfer from microarrays to PCR

British journal of cancer, 2012-10, Vol.107 (8), p.1392-1398

2012

Volltextzugriff (PDF)

Low ANXA10 expression is associated with disease aggressiveness in bladder cancer

British journal of cancer, 2011-10, Vol.105 (9), p.1379-1387

2011

Volltextzugriff (PDF)

2537 Preliminary findings from PLATO: A two-period, phase 4, randomized, double-blind, placebo-controlled study of continued enzalutamide treatment beyond progression in men with chemotherapy-naïve metastatic castration-resistant prostate cancer (mCRPC)

European journal of cancer (1990), 2015-09, Vol.51, p.S487-S487

2015

Volltextzugriff (PDF)

Detection of Mycoplasma genitalium by PCR Amplification of the 16S rRNA Gene

Journal of Clinical Microbiology, 2003-01, Vol.41 (1), p.261-266

2003

Volltextzugriff (PDF)

Optical properties and instrumental performance of thin gold films near the surface plasmon resonance

Thin solid films, 2006-02, Vol.496 (2), p.688-697

2006

Volltextzugriff (PDF)

Preoperative risk factors related to bladder cancer rehabilitation: a registry study

European journal of clinical nutrition, 2013-09, Vol.67 (9), p.917-921

2013

Volltextzugriff (PDF)

Diffractive optical coupling element for surface plasmon resonance sensors

Sensors and actuators. B, Chemical, 2004-05, Vol.100 (3), p.298-308

2004

Volltextzugriff (PDF)

Utility of circulating tumor DNA methylation biomarkers in newly diagnosed prostate cancer

European urology open science (Online), 2020-07, Vol.19, p.e1670

2020

Volltextzugriff (PDF)

Quantification of angiogenesis as a prognostic marker in human carcinomas: a critical evaluation of histopathological methods for estimation of vascular density

European journal of cancer (1990), 2003-05, Vol.39 (7), p.881-890

2003

Volltextzugriff (PDF)

Internet‐delivered mindfulness‐based cognitive therapy for anxiety and depression in cancer survivors: A randomized controlled trial

Psycho-oncology (Chichester, England), 2020-01, Vol.29 (1), p.68-75

2020

Volltextzugriff (PDF)

Microvessel density predicts survival in prostate cancer patients subjected to watchful waiting

British journal of cancer, 1998-10, Vol.78 (7), p.940-944

1998

Volltextzugriff (PDF)

Genome-wide analysis of allelic imbalance in prostate cancer using the Affymetrix 50K SNP mapping array

British journal of cancer, 2007-02, Vol.96 (3), p.499-506

2007

Volltextzugriff (PDF)

MON-PO376: The Use of Biologically-Based Complementary Medicines in Patients with Neuroendocrine Tumours

Clinical nutrition (Edinburgh, Scotland), 2019-09, Vol.38, p.S197-S198

2019

Volltextzugriff (PDF)

Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer

The New England journal of medicine, 2017-07, Vol.377 (4), p.352-360

2017

Volltextzugriff (PDF)

Detection of the Factor V Leiden Mutation by Direct Allele-specific Hybridization of PCR Amplicons to Photoimmobilized Locked Nucleic Acids

Clinical chemistry (Baltimore, Md.), 1999-11, Vol.45 (11), p.1898-1905

1999

Volltextzugriff (PDF)

Enzalutamide and Survival in Nonmetastatic, Castration-Resistant Prostate Cancer

The New England journal of medicine, 2020-06, Vol.382 (23), p.2197-2206

2020

Volltextzugriff (PDF)

1186 Nordic Lifestyle Intervention Trial on Prostate Cancer Progression (NILS)

European journal of cancer (1990), 2012-07, Vol.48, p.S286-S286

2012

Volltextzugriff (PDF)

1 – 25 von 431

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(346)
Mit Volltextzugriff
(359)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(5)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Expression of MAGE-A3, NY-ESO-1, LAGE-1 and PRAME in urothelial carcinoma

The miR-143/-145 cluster regulates plasminogen activator inhibitor-1 in bladder cancer

Training and validation of a novel 4-miRNA ratio model (MiCaP) for prediction of postoperative outcome in prostate cancer patients

miR-145 induces caspase-dependent and -independent cell death in urothelial cancer cell lines with targeting of an expression signature present in Ta bladder tumors

PT08.2: Nutritional Status and Nutritional Risk in Patients with Neuroendocrine Tumors

A high resolution genomic portrait of bladder cancer: correlation between genomic aberrations and the DNA damage response

Prognostic significance of aberrantly silenced ANPEP expression in prostate cancer

Next-generation sequencing identifies germline MRE11A variants as markers of radiotherapy outcomes in muscle-invasive bladder cancer

Analysis of molecular intra-patient variation and delineation of a prognostic 12-gene signature in non-muscle invasive bladder cancer; technology transfer from microarrays to PCR

Low ANXA10 expression is associated with disease aggressiveness in bladder cancer

2537 Preliminary findings from PLATO: A two-period, phase 4, randomized, double-blind, placebo-controlled study of continued enzalutamide treatment beyond progression in men with chemotherapy-naïve metastatic castration-resistant prostate cancer (mCRPC)

Detection of Mycoplasma genitalium by PCR Amplification of the 16S rRNA Gene

Optical properties and instrumental performance of thin gold films near the surface plasmon resonance

Preoperative risk factors related to bladder cancer rehabilitation: a registry study

Diffractive optical coupling element for surface plasmon resonance sensors

Utility of circulating tumor DNA methylation biomarkers in newly diagnosed prostate cancer

Quantification of angiogenesis as a prognostic marker in human carcinomas: a critical evaluation of histopathological methods for estimation of vascular density

Internet‐delivered mindfulness‐based cognitive therapy for anxiety and depression in cancer survivors: A randomized controlled trial

Microvessel density predicts survival in prostate cancer patients subjected to watchful waiting

Genome-wide analysis of allelic imbalance in prostate cancer using the Affymetrix 50K SNP mapping array

MON-PO376: The Use of Biologically-Based Complementary Medicines in Patients with Neuroendocrine Tumours

Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer

Detection of the Factor V Leiden Mutation by Direct Allele-specific Hybridization of PCR Amplicons to Photoimmobilized Locked Nucleic Acids

Enzalutamide and Survival in Nonmetastatic, Castration-Resistant Prostate Cancer

1186 Nordic Lifestyle Intervention Trial on Prostate Cancer Progression (NILS)

Suchergebnisse filtern